The global consumer genomics market size was USD 1.62 billion in 2023, calculated at USD 2.03 billion in 2024 and is projected to surpass around USD 18.83 billion by 2034, expanding at a CAGR of 24.9% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Consumer Genomics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Consumer Genomics Market, by Applications Type, 2024-2034
8.1.1. Genetic Relatedness
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Diagnostics
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Lifestyle, Wellness, & Nutrition
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Ancestry
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Reproductive Health
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Personalized Medicine & Pharmacogenetic testing
8.1.6.1. Market Revenue and Forecast (2021-2034)
8.1.7. Sports Nutrition & Health
8.1.7.1. Market Revenue and Forecast (2021-2034)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2021-2034)
9.1. North America
9.1.1. Market Revenue and Forecast, by Applications (2021-2034)
9.1.2. U.S.
9.1.2.1. Market Revenue and Forecast, by Applications (2021-2034)
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Applications (2021-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Applications (2021-2034)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Applications (2021-2034)
9.2.3. Germany
9.2.3.1. Market Revenue and Forecast, by Applications (2021-2034)
9.2.4. France
9.2.4.1. Market Revenue and Forecast, by Applications (2021-2034)
9.2.5. Rest of Europe
9.2.5.1. Market Revenue and Forecast, by Applications (2021-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Applications (2021-2034)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Applications (2021-2034)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Applications (2021-2034)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Applications (2021-2034)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Applications (2021-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Applications (2021-2034)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Applications (2021-2034)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Applications (2021-2034)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Applications (2021-2034)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Applications (2021-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Applications (2021-2034)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Applications (2021-2034)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Applications (2021-2034)
10.1. Ancestry
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Gene By Gene, Ltd. (FamilyTree DNA)
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. 23andMe, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Color Genomics, Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Myriad Genetics, Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Mapmygenome
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Positive Biosciences, Ltd.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Futura Genetics
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Helix OpCo LLC
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. MyHeritage Ltd.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample